GC Corp. (KRX:005250)

Market Cap	460.37B -32.8%
Revenue (ttm)	2.49T +9.6%
Net Income	-121.43B
EPS	-2,701.53
Shares Out	45.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	300.00 (2.98%)
Ex-Dividend Date	Mar 30, 2026

Volume	52,878
Open	10,130
Previous Close	10,010
Day's Range	9,900 - 10,180
52-Week Range	8,630 - 18,010
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About GC Corp.

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; a...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Employees: 144
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 30, 2026

Data Sources Report a data error